HCPLive

MARCH 25, 2025

Mitchell reviews FDA-approved drugs for reducing alcohol use, which ones can be used in patients with liver disease, and other therapies on the horizon.

52

52

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

ObjectivesExercise training is a rehabilitative approach to improve cardiac function in patients with myocardial infarction. However, evidence on the effectiveness of exercise training in these patients remains limited. In this meta-analysis, we aim to evaluate the extent to which exercise training improves cardiac function in patients with myocardial infarction.MethodsWe conducted a systematic search of the PubMed, Embase, Cochrane Library, and Web of Science databases to compare cardiac functi

Myocardial Infarction 52

Myocardial Infarction Exercise Cardiac Function Pharmacology 52

The American Journal of Cardiology

MARCH 25, 2025

Publication date: Available online 25 March 2025 Source: The American Journal of Cardiology Author(s): Da-Eun Sung, Da-Youn Lee, Eun-Jung Rhee

40

40

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

ObjectivesNoise pollution has become an increasingly severe environmental issue in modern society and has been recognized for its adverse effects on cardiovascular diseases. Hypertension induced by noise exposure has garnered significant research interest and a large quantity of studies have been conducted. This study aims to employ bibliometric methods to comprehensively review the literature on the relationship between noise exposure and hypertension and to analyze the current state of researc

Hypertension 52

Hypertension Public Health Research Physiology 52

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Patient Care

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

Cardio-cerebral infarction (CCI) is a rare clinical syndrome characterized by the simultaneous or sequential occurrence of acute myocardial infarction (AMI) and acute ischemic stroke (AIS). Despite its complex pathogenesis and more severe prognosis compared to isolated AMI or AIS, no consensus has been established regarding its definition, classification, epidemiology, treatment protocols, or prognostic management.

Myocardial Infarction 52

Myocardial Infarction Article Research Patient Care 52

Frontiers in Cardiovascular Medicine

MARCH 25, 2025

Chronic kidney disease (CKD) is a progressive condition characterized by the gradual loss of kidney function, leading to the accumulation of uremic toxins in the bloodstream. These toxins play a pivotal role in mediating vascular inflammation, a key contributor to the high cardiovascular morbidity and mortality observed in CKD patients. This review article explores the intricate mechanisms by which uremic toxins accelerate vascular inflammation.

Kidney Disease 52

Kidney Disease Article Risk Factors 52